The tubeless insulin pump market size has grown rapidly in recent years. It will grow from $2.2 billion in 2025 to $2.63 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to limited availability of tubeless insulin pumps, reliance on conventional insulin delivery methods, increasing prevalence of diabetes, growing hospital adoption of insulin pumps, early integration of basic cgm systems.
The tubeless insulin pump market size is expected to see rapid growth in the next few years. It will grow to $5.28 billion in 2030 at a compound annual growth rate (CAGR) of 19%. The growth in the forecast period can be attributed to development of advanced wearable and implantable insulin pumps, rising integration of ai and smart monitoring systems, expansion of remote patient monitoring, increasing patient awareness and adoption, growth in e-commerce and telemedicine channels. Major trends in the forecast period include growing adoption of wearable insulin pumps among diabetic patients, integration of continuous glucose monitoring (cgm) with tubeless pumps, demand for bluetooth-enabled and remote-controlled pumps, increasing preference for disposable and reusable patch pumps, expansion of e-commerce channels for insulin pump distribution.
The rising prevalence of diabetes is expected to drive the growth of the tubeless insulin pump market in the coming years. Diabetes is a chronic condition characterized by high blood sugar due to the body’s inability to produce or effectively use insulin. The increase in diabetes cases is largely linked to rising obesity rates, which are strongly associated with poor diet and physical inactivity. Tubeless insulin pumps help manage diabetes by delivering continuous, controlled doses of insulin without the need for multiple daily injections, effectively regulating blood sugar levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This number is projected to more than double, reaching 1.3 billion by 2050. Consequently, the growing prevalence of diabetes is fueling demand for tubeless insulin pumps.
Key players in the tubeless insulin pump market are focusing on developing advanced solutions, such as basal-only insulin pods, to provide simplified and cost-effective insulin delivery for individuals with type 2 diabetes who require only background insulin support. A basal-only insulin pod is a wearable pump that delivers a continuous background dose of insulin to help control blood sugar levels, primarily for those with type 2 diabetes. In April 2023, Insulet Corporation, a US-based medical device company, launched Omnipod GO, an insulin delivery device approved for use in adults with type 2 diabetes who would normally receive daily long-acting insulin injections. Omnipod GO is a wearable, independent device that delivers a constant rate of rapid-acting insulin for 72 hours. The tubeless and waterproof pod comes in seven pre-programmed daily rates ranging from 10 to 40 units and operates without the need for a mobile device.
In January 2023, Tandem Diabetes Care, a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. This acquisition supports Tandem’s sustainability initiatives by reducing battery waste through the Sigi pump’s rechargeable design while expanding its portfolio of advanced insulin delivery solutions. AMF Medical SA, based in Switzerland, specializes in the manufacture of reusable patch (tubeless) insulin pumps.
Major companies operating in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, Beta Bionics.
North America was the largest region in the tubeless insulin pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tubeless insulin pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tubeless insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the tubeless insulin pump market by increasing the cost of imported components such as bluetooth modules, cgm sensors, and medical-grade polymers. Segments like wearable and bluetooth-enabled pumps are particularly impacted, with regions including North America and Asia-Pacific facing higher import duties. This has led to elevated production costs and potential price increases for end users. On the positive side, tariffs have encouraged domestic manufacturing, stimulated innovation in pump technology, and supported local supply chain development.
The tubeless insulin pump market research report is one of a series of new reports that provides tubeless insulin pump market statistics, including tubeless insulin pump industry global market size, regional shares, competitors with a tubeless insulin pump market share, detailed tubeless insulin pump market segments, market trends and opportunities, and any further data you may need to thrive in the tubeless insulin pump industry. This tubeless insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A tubeless insulin pump is a wearable medical device designed for people with diabetes to provide continuous insulin delivery without the use of external tubing. It adheres directly to the skin and communicates wirelessly with a handheld controller, offering a more convenient and discreet method of insulin administration.
The primary types of tubeless insulin pumps include wearable and implantable insulin pumps. Wearable pumps are compact devices worn on the body that administer continuous doses of short-acting insulin subcutaneously, minimizing the need for multiple daily injections. These pumps utilize technologies such as continuous glucose monitoring (CGM), integrated pump systems, and standard tubeless pumps, and are utilized by end users including hospitals, pharmacies, e-commerce platforms, and others.
The tubeless insulin pump market consists of sales of infusion sets, insertion tools, adhesives pods, and handheld or smartphone-based controllers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The tubeless insulin pump market size is expected to see rapid growth in the next few years. It will grow to $5.28 billion in 2030 at a compound annual growth rate (CAGR) of 19%. The growth in the forecast period can be attributed to development of advanced wearable and implantable insulin pumps, rising integration of ai and smart monitoring systems, expansion of remote patient monitoring, increasing patient awareness and adoption, growth in e-commerce and telemedicine channels. Major trends in the forecast period include growing adoption of wearable insulin pumps among diabetic patients, integration of continuous glucose monitoring (cgm) with tubeless pumps, demand for bluetooth-enabled and remote-controlled pumps, increasing preference for disposable and reusable patch pumps, expansion of e-commerce channels for insulin pump distribution.
The rising prevalence of diabetes is expected to drive the growth of the tubeless insulin pump market in the coming years. Diabetes is a chronic condition characterized by high blood sugar due to the body’s inability to produce or effectively use insulin. The increase in diabetes cases is largely linked to rising obesity rates, which are strongly associated with poor diet and physical inactivity. Tubeless insulin pumps help manage diabetes by delivering continuous, controlled doses of insulin without the need for multiple daily injections, effectively regulating blood sugar levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This number is projected to more than double, reaching 1.3 billion by 2050. Consequently, the growing prevalence of diabetes is fueling demand for tubeless insulin pumps.
Key players in the tubeless insulin pump market are focusing on developing advanced solutions, such as basal-only insulin pods, to provide simplified and cost-effective insulin delivery for individuals with type 2 diabetes who require only background insulin support. A basal-only insulin pod is a wearable pump that delivers a continuous background dose of insulin to help control blood sugar levels, primarily for those with type 2 diabetes. In April 2023, Insulet Corporation, a US-based medical device company, launched Omnipod GO, an insulin delivery device approved for use in adults with type 2 diabetes who would normally receive daily long-acting insulin injections. Omnipod GO is a wearable, independent device that delivers a constant rate of rapid-acting insulin for 72 hours. The tubeless and waterproof pod comes in seven pre-programmed daily rates ranging from 10 to 40 units and operates without the need for a mobile device.
In January 2023, Tandem Diabetes Care, a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. This acquisition supports Tandem’s sustainability initiatives by reducing battery waste through the Sigi pump’s rechargeable design while expanding its portfolio of advanced insulin delivery solutions. AMF Medical SA, based in Switzerland, specializes in the manufacture of reusable patch (tubeless) insulin pumps.
Major companies operating in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, Beta Bionics.
North America was the largest region in the tubeless insulin pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tubeless insulin pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tubeless insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the tubeless insulin pump market by increasing the cost of imported components such as bluetooth modules, cgm sensors, and medical-grade polymers. Segments like wearable and bluetooth-enabled pumps are particularly impacted, with regions including North America and Asia-Pacific facing higher import duties. This has led to elevated production costs and potential price increases for end users. On the positive side, tariffs have encouraged domestic manufacturing, stimulated innovation in pump technology, and supported local supply chain development.
The tubeless insulin pump market research report is one of a series of new reports that provides tubeless insulin pump market statistics, including tubeless insulin pump industry global market size, regional shares, competitors with a tubeless insulin pump market share, detailed tubeless insulin pump market segments, market trends and opportunities, and any further data you may need to thrive in the tubeless insulin pump industry. This tubeless insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A tubeless insulin pump is a wearable medical device designed for people with diabetes to provide continuous insulin delivery without the use of external tubing. It adheres directly to the skin and communicates wirelessly with a handheld controller, offering a more convenient and discreet method of insulin administration.
The primary types of tubeless insulin pumps include wearable and implantable insulin pumps. Wearable pumps are compact devices worn on the body that administer continuous doses of short-acting insulin subcutaneously, minimizing the need for multiple daily injections. These pumps utilize technologies such as continuous glucose monitoring (CGM), integrated pump systems, and standard tubeless pumps, and are utilized by end users including hospitals, pharmacies, e-commerce platforms, and others.
The tubeless insulin pump market consists of sales of infusion sets, insertion tools, adhesives pods, and handheld or smartphone-based controllers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Tubeless Insulin Pump Market Characteristics
3. Tubeless Insulin Pump Market Supply Chain Analysis
4. Global Tubeless Insulin Pump Market Trends and Strategies
5. Tubeless Insulin Pump Market Analysis of End Use Industries
7. Global Tubeless Insulin Pump Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Tubeless Insulin Pump Total Addressable Market (TAM) Analysis for the Market
9. Tubeless Insulin Pump Market Segmentation
10. Tubeless Insulin Pump Market Regional and Country Analysis
11. Asia-Pacific Tubeless Insulin Pump Market
12. China Tubeless Insulin Pump Market
13. India Tubeless Insulin Pump Market
14. Japan Tubeless Insulin Pump Market
15. Australia Tubeless Insulin Pump Market
16. Indonesia Tubeless Insulin Pump Market
17. South Korea Tubeless Insulin Pump Market
18. Taiwan Tubeless Insulin Pump Market
19. South East Asia Tubeless Insulin Pump Market
20. Western Europe Tubeless Insulin Pump Market
21. UK Tubeless Insulin Pump Market
22. Germany Tubeless Insulin Pump Market
23. France Tubeless Insulin Pump Market
24. Italy Tubeless Insulin Pump Market
25. Spain Tubeless Insulin Pump Market
26. Eastern Europe Tubeless Insulin Pump Market
27. Russia Tubeless Insulin Pump Market
28. North America Tubeless Insulin Pump Market
29. USA Tubeless Insulin Pump Market
30. Canada Tubeless Insulin Pump Market
31. South America Tubeless Insulin Pump Market
32. Brazil Tubeless Insulin Pump Market
33. Middle East Tubeless Insulin Pump Market
34. Africa Tubeless Insulin Pump Market
36. Tubeless Insulin Pump Market Competitive Landscape and Company Profiles
37. Tubeless Insulin Pump Market Other Major and Innovative Companies
40. Tubeless Insulin Pump Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Tubeless Insulin Pump Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses tubeless insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for tubeless insulin pump? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tubeless insulin pump market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Wearable Insulin Pump; Implantable Insulin Pump2) By Technology: Continuous Glucose Monitoring (CGM) Integrated Pumps; Standard Tubeless Pumps
3) By End User: Hospitals; Pharmacies; E-Commerce; Other End Users
Subsegments:
1) By Wearable Insulin Pump: Patch Pumps; Remote-Controlled Pumps; Bluetooth-Enabled Pumps; Disposable Pumps; Reusable Pumps2) By Implantable Insulin Pump: Programmable Implantable Pumps; Refillable Implantable Pumps; Microelectromechanical System (MEMS)-Based Pumps; Long-Acting Implantable Pumps; Biocompatible Coated Pumps
Companies Mentioned: F. Hoffmann-La Roche AG; Sanofi SA; Abbott Laboratories; Medtronic plc; Eli Lilly and Company; Becton Dickinson & Company; Fresenius Kabi AG; Terumo Corporation; Insulet Corporation; Tandem Diabetes Care Inc.; Ypsomed AG; Ascensia Diabetes Care; MicroTech Medical; Menarini Diagnostics; Bigfoot Biomedical; Debiotech SA; Medtrum Technologies Inc.; Diabeloop; SOOIL Development; Beta Bionics.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Tubeless Insulin Pump market report include:- F. Hoffmann-La Roche AG
- Sanofi SA
- Abbott Laboratories
- Medtronic plc
- Eli Lilly and Company
- Becton Dickinson & Company
- Fresenius Kabi AG
- Terumo Corporation
- Insulet Corporation
- Tandem Diabetes Care Inc.
- Ypsomed AG
- Ascensia Diabetes Care
- MicroTech Medical
- Menarini Diagnostics
- Bigfoot Biomedical
- Debiotech SA
- Medtrum Technologies Inc.
- Diabeloop
- SOOIL Development
- Beta Bionics.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.63 Billion |
| Forecasted Market Value ( USD | $ 5.28 Billion |
| Compound Annual Growth Rate | 19.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
